Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy

Author： Friedman A.N.   Hunsicker L.G.   Selhub J.   Bostom A.G.   The Collaborative Study Group  

Publisher： Elsevier

ISSN： 0021-9150

Source： Atherosclerosis, Vol.172, Iss.1, 2004-01, pp. : 121-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Decrease in serum C-reactive protein levels by troglitazone is associated with pretreatment insulin resistance, but independent of its effect on glycemia, in type 2 diabetic subjects

By Yatagai T.   Nakamura T.   Nagasaka S.   Kusaka I.   Ishikawa S.-e.   Yoshitaka A.   Ishibashi S.  

Diabetes Research and Clinical Practice, Vol. 63, Iss. 1, 2004-01 ,pp. : 19-26

Elsevier

Access to resources Recommend Favorite

Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome

By Akbar Daad  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 215-218

Humana Press, Inc

Access to resources Recommend Favorite

Correlation of C-Reactive Protein with Clinical and Endoscopic Activity in Patients with Ulcerative Colitis

By Karoui Sami   Laz Sonia   Serghini Meriem   Bibani Norsaf   Boubaker Jalel   Filali Azza  

Digestive Diseases and Sciences, Vol. 56, Iss. 6, 2011-06 ,pp. : 1801-1805

Springer Publishing Company

Access to resources Recommend Favorite

C-reactive protein: history and revival

By Ablij H.C.   Meinders A.E.  

European Journal of Internal Medicine, Vol. 13, Iss. 7, 2002-10 ,pp. : 412-422

Elsevier

Access to resources Recommend Favorite

C-Reactive Protein and Atherosclerosis: An Update

By  

Vascular Disease Prevention, Vol. 5, Iss. 3, 2008-08 ,pp. : 178-182

Bentham Science Publishers

Access to resources Recommend Favorite